Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: Translational Models for Drug-Induced Liver Injury
7:40 pm - 7:55 pm
Opening Remarks
7:55 pm - 8:55 pm
"Translational Models for Drug-Induced Liver Injury"
8:55 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
New Models for Predicting Human Pharmacokinetics
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"The Role of Microfluidic/Microphysiologic Systems for Studying Drug Transport"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"PET Imaging for In Vivo Determination of Pharmacokinetic Parameters"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
"The Extended Clearance Concept: Identification of Clinically Relevant Drug Transporters and DDI Risks in Early Drug Development"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
"Developing Improved Pharmacokinetic Models for Therapeutic Antibodies"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
3:00 pm - 4:00 pm
The GRC Power Hourâ„¢
The GRC Power Hourâ„¢ is designed to address challenges women face in science and issues of diversity and inclusion. The program supports the professional growth of all members of our communities by providing an open forum for discussion and mentoring.
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Predicting Human PK, PK/PD and Efficacious Dose
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"What We Know and Don't Know About PK/PD Relationships for Therapeutic siRNA"
8:00 pm - 8:10 pm
Discussion
8:10 pm - 8:35 pm
"Human Pharmacokinetic and Dose Predictions in Immunology and Immuno-Oncology: Considerations and Case Studies"
8:35 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
"Leveraging Mechanistic Models to Inform Drug Design and Early Clinical Development"
9:15 pm - 9:30 pm
Discussion
Tuesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Translational Approaches to Untangle Xenobiotic-Drug Interaction Mechanisms and Improve Pharmacotherapy
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"Optimizing In Vitro Tools for Successful Translation of Time-Dependent Inhibitors"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Variety Is the Spice of Life: Pre-Clinical Approaches to Evaluate Mechanisms of Cinnamaldehyde-Drug Interactions"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
"Cannabinoid-Drug Interactions: Getting into the Weeds"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
"Clinical Approaches to Untangle Complex Drug-Drug Interaction Mechanisms"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Translational Biomarkers for Transporter Function and Toxicity
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"Overview of Transporter DDI Biomarkers: Where We Are and Where We Are Going"
8:00 pm - 8:15 pm
Discussion
8:15 pm - 8:40 pm
"Translational Mechanistic Safety Biomarkers in Drug Development"
8:40 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
"Safety Assessment of Acyl Glucuronides: Approach the Problems that Drive Toxicity"
9:15 pm - 9:30 pm
Discussion
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Predictive Models for Liver and Kidney Toxicity
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"High Throughput Transcriptomics in Metabolically Competent Hepatic Spheroid Models for Chemical Screening and Prioritization at the NTP"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Utilization of Direct CD8+ T Cell Activation Mathematical Model Groundwork in Preliminary Amodiaquine-Based iDILI Model"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
"Urinary miRNA Biomarkers of Kidney Toxicity and Their Site Specificity Within the Renal Nephron: A HESI Consortium Effort"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
"In Vitro 3D Renal Organoids Generated from Human Urine-Derived Stem Cells for Nephrotoxicity Testing"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:00 pm - 7:30 pm
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
7:30 pm - 9:30 pm
Young Investigator Presentations
7:30 pm - 7:45 pm
"The Potential of Cannabinoids to Precipitate Drug Interactions"
7:45 pm - 7:50 pm
Discussion
7:50 pm - 8:05 pm
"The Abundant DNA Adduct N7-Methyl Deoxyguanosine Contributes to Miscoding During Replication by Human DNA Polymerase?"
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:25 pm
"Exploring Beyond the Steady State: Kinetic Evaluations of In Vitro CYP and AO Inhibition"
8:25 pm - 8:30 pm
Discussion
8:30 pm - 8:45 pm
"CNS Delivery of VX-970: A Selective ATR Inhibitor for Radiosensitization in GBM"
8:45 pm - 8:50 pm
Discussion
8:50 pm - 9:05 pm
"Assessing Transporter-Mediated Goldenseal-Drug Interactions in Healthy Volunteers Using a Transporter Cocktail"
9:05 pm - 9:10 pm
Discussion
9:10 pm - 9:25 pm
"Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies"
9:25 pm - 9:30 pm
Discussion
Thursday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Understanding Hydrolases for Clinical Outcomes
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:35 am
"Improving Peptide Exposure"
9:35 am - 9:50 am
Discussion
9:50 am - 10:20 am
"Carboxylesterases and Arylacetamide Deacetylase: Drug Metabolizing Enzymes Moonlighting as Lipid Hydrolases. Or Is It Vice Versa ?"
10:20 am - 10:35 am
Discussion
10:35 am - 11:00 am
Coffee Break
11:00 am - 11:30 am
"What a Difference a Species Makes: Enzymatic Hydrolysis"
11:30 am - 11:45 am
Discussion
11:45 am - 12:15 pm
"Oral and Intracellular Delivery of Macromolecules: Two Targets for the Price of One"
12:15 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:00 pm
Free Time
4:00 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
The Importance of Understanding Metabolite Profiles
7:30 pm - 7:35 pm
Introduction by Discussion Leader
7:35 pm - 8:00 pm
"Adventures in Biotransformation: Metabolites and the Enzymes and Mechanisms that Form Them"
8:00 pm - 8:10 pm
Discussion
8:10 pm - 8:35 pm
"Metabolites and Their Relevance for Human Safety: From In Vitro to In Vivo "
8:35 pm - 8:50 pm
Discussion
8:50 pm - 9:15 pm
"Drug Activation via Phosphorylation"
9:15 pm - 9:30 pm
Discussion
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure